D Daiichi Sankyo
Updates & Highlights
marketscreener.com · about 11 hours ago
AstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2 Positive Breast Cancer
Moomoo · 1 day ago
Special Report on Shareholding Daiichi Sankyo (7.39% → 7.97%) Blackrock Japan, et al.
TradingView · 3 days ago
Fortis Healthcare Filed Special Leave Petition Before Supreme Court In Daiichi Sankyo Case
Recent Openings
View all 1 jobs arrow_forwardData Scientist - Pharmaceutical Development and Manufacturing (m/f/d)
location_on Pfaffenhofen an der Ilm, BY, DE
All Jobs
Data Scientist - Pharmaceutical Development and Manufacturing (m/f/d)
location_on Pfaffenhofen an der Ilm, BY, DE
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Daiichi Sankyo?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentAstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2 Positive Breast Cancer
AstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2 Positive Breast Cancer
marketscreener.com · about 11 hours ago
Special Report on Shareholding Daiichi Sankyo (7.39% → 7.97%) Blackrock Japan, et al.
Special Report on Shareholding Daiichi Sankyo (7.39% → 7.97%) Blackrock Japan, et al.
Moomoo · 1 day ago
Fortis Healthcare Filed Special Leave Petition Before Supreme Court In Daiichi Sankyo Case
Fortis Healthcare Filed Special Leave Petition Before Supreme Court In Daiichi Sankyo Case
TradingView · 3 days ago
AstraZeneca, Daiichi Sankyo’s ENHERTU Cuts Disease Progression Risk by 37% in HER2-Mutant Lung Cancer
AstraZeneca, Daiichi Sankyo’s ENHERTU Cuts Disease Progression Risk by 37% in HER2-Mutant Lung Cancer
BioPharma APAC · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q3 2023 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q3 2023 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q4 2023 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q4 2023 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q1 2024 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q1 2024 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q4 2024 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q4 2024 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q1 2025 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q1 2025 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q4 2024 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q4 2024 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q2 2025 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q2 2025 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q3 2025 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q3 2025 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q2 2024 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q2 2024 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company Limited (D4S) Q4 2025 Earnings Report - Results, Call & Slides
Daiichi Sankyo Company Limited (D4S) Q4 2025 Earnings Report - Results, Call & Slides
TipRanks · 3 days ago
Daiichi Sankyo Company (TSE:4568) Could Be 31% Below Fair Value As Legal Risk Clears
Daiichi Sankyo Company (TSE:4568) Could Be 31% Below Fair Value As Legal Risk Clears
Yahoo Finance · 4 days ago
Enhertu EU Milestone And Legal Win Might Change The Case For Investing In Daiichi Sankyo (TSE:4568)
Enhertu EU Milestone And Legal Win Might Change The Case For Investing In Daiichi Sankyo (TSE:4568)
Yahoo Finance · 4 days ago
Enhertu EU Milestone And Legal Win Might Change The Case For Investing In Daiichi Sankyo (TSE:4568)
Enhertu EU Milestone And Legal Win Might Change The Case For Investing In Daiichi Sankyo (TSE:4568)
Yahoo Finance UK · 4 days ago
Daiichi Sankyo, AstraZeneca's sBLA for Enhertu in Gastric Cancer Accepted by FDA
Daiichi Sankyo, AstraZeneca's sBLA for Enhertu in Gastric Cancer Accepted by FDA
GenomeWeb · 5 days ago
Daiichi Sankyo Company (TSE:4568) Wins EU Approval For Enhertu, Is The Stock A Bargain?
Daiichi Sankyo Company (TSE:4568) Wins EU Approval For Enhertu, Is The Stock A Bargain?
simplywall.st · 6 days ago
AstraZeneca, Daiichi Sankyo to Discuss Pan-Cancer Enhertu Activity With Regulators
AstraZeneca, Daiichi Sankyo to Discuss Pan-Cancer Enhertu Activity With Regulators
GenomeWeb · 7 days ago